Ass'n for Molecular Pathology v. Myriad Genetics, Inc.

569 U.S. 902, 185 L. Ed. 2d 783, 133 S. Ct. 1747, 81 U.S.L.W. 3554, 2013 WL 1285311, 2013 U.S. LEXIS 2627
CourtSupreme Court of the United States
DecidedApril 1, 2013
DocketNo. 12–398.
StatusPublished

This text of 569 U.S. 902 (Ass'n for Molecular Pathology v. Myriad Genetics, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 902, 185 L. Ed. 2d 783, 133 S. Ct. 1747, 81 U.S.L.W. 3554, 2013 WL 1285311, 2013 U.S. LEXIS 2627 (2013).

Opinion

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument granted, and the time is to be divided as follows: 25 minutes for petitioners, 10 minutes for the Solicitor General, and 30 minutes for respondents.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
569 U.S. 902, 185 L. Ed. 2d 783, 133 S. Ct. 1747, 81 U.S.L.W. 3554, 2013 WL 1285311, 2013 U.S. LEXIS 2627, Counsel Stack Legal Research, https://law.counselstack.com/opinion/assn-for-molecular-pathology-v-myriad-genetics-inc-scotus-2013.